A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR.

This corrects the article DOI: 10.1038/cdd.2016.22.

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5520161	PMC
http://dx.doi.org/10.1038/cdd.2016.43	DOI Listing

Publication Analysis

novel treatment

treatment cystic

cystic fibrosis

fibrosis acting

acting on-target

on-target cysteamine

cysteamine epigallocatechin

epigallocatechin gallate

gallate autophagy-dependent

autophagy-dependent rescue

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!